Quick Dispatch:
Your glp-1 and crohn's disease Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectives | Naunyn-Schmiedeberg's Archives of Pharmacology orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your glp-1 and crohn's disease Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectives | Naunyn-Schmiedeberg's Archives of Pharmacology ships.
Need Help?
Questions about glp-1 and crohn's disease Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectives | Naunyn-Schmiedeberg's Archives of Pharmacology, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for glp-1 and crohn's disease Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectives | Naunyn-Schmiedeberg's Archives of Pharmacology in your area.
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
28.27
The alleviating effect and mechanism of GLP-1 on ulcerative colitis
27.42
Ozempic and Crohn's Disease: Could GLP-1s Help?
26.51
GLP-1 RAs and Crohn's Disease
22.38
Heavy arch: from inflammatory bowel diseases to metabolic disorders
25.81
GLP-1 Medications: Reimagining the Treatment Paradigm for Severe Crohn's Disease
21.15
New research published in the Foundation's journal Crohn's & Colitis 360 found that people with IBD who use GLP-1 medications—commonly prescribed for diabetes and obesity—had a lower risk of major heart-related complications
20.27
